camrelizumab

Trials studying camrelizumab

• phase3Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)active not recruitingn=231
• phase2Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasiarecruitingn=70
• phase3Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJCrecruitingn=550
• phase2A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCCrecruitingn=120
• phase3A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancerrecruitingn=502
• phase3A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablationactive not recruitingn=687
• phase3A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinomaactive not recruitingn=423
• N/APD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCTrecruitingn=43